RASAGILINE MESYLATE

RASAGILINE MESYLATE was reported 11266 times

RASAGILINE MESYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DOPAMINE AGONIST WITHDRAWAL SYNDROME 12 0.2222
1 CEREBRAL HYPOPERFUSION 75 0.1609
2 BINOCULAR EYE MOVEMENT DISORDER 35 0.1215
3 DOPAMINE DYSREGULATION SYNDROME 47 0.1054
4 CEREBELLAR STROKE 36 0.0921
5 SUPINE HYPERTENSION 17 0.0899
6 BLOOD LACTIC ACID 10 0.0775
7 PARAPHILIA 10 0.0769
8 JEALOUS DELUSION 20 0.0707
9 HYPERSEXUALITY 120 0.0656
10 OBSESSIVE-COMPULSIVE PERSONALITY DISORDER 16 0.0632
11 FREEZING PHENOMENON 219 0.0591
12 STOMA SITE INDURATION 7 0.0588
13 IMPULSE-CONTROL DISORDER 116 0.0563
14 ON AND OFF PHENOMENON 294 0.0529
15 STOMA SITE HYPERGRANULATION 32 0.0507
16 RESTING TREMOR 31 0.0480
17 AMIMIA 5 0.0455
18 SALIVA DISCOLOURATION 15 0.0449
19 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 18 0.0448
20 STOMA SITE ERYTHEMA 78 0.0417
21 CAMPTOCORMIA 10 0.0417
22 BENIGN NEOPLASM OF ADRENAL GLAND 6 0.0400
23 PATHOLOGICAL GAMBLING 61 0.0367
24 DEEP BRAIN STIMULATION 22 0.0364
25 STOMA SITE DISCHARGE 97 0.0354
26 STOMA SITE DISCOMFORT 8 0.0352
27 ENTEROBIASIS 5 0.0336
28 SUDDEN ONSET OF SLEEP 44 0.0317
29 STOMA SITE INFECTION 41 0.0315
30 CATHETER SITE NODULE 6 0.0314
31 STOMA SITE ODOUR 7 0.0312
32 CATHETER SITE INDURATION 6 0.0311
33 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 15 0.0301
34 REDUCED FACIAL EXPRESSION 30 0.0296
35 MESENTERIC ARTERY THROMBOSIS 11 0.0286
36 STOMA SITE EXTRAVASATION 11 0.0285
37 POSTURAL TREMOR 8 0.0274
38 STOMA SITE OEDEMA 6 0.0274
39 CATHETER SITE BRUISE 9 0.0272
40 THUNDERCLAP HEADACHE 7 0.0267
41 COMPULSIVE SHOPPING 54 0.0262
42 AKINESIA 54 0.0260
43 STOMA SITE IRRITATION 14 0.0257
44 HYPORESPONSIVE TO STIMULI 30 0.0255
45 SLEEP ATTACKS 12 0.0252
46 COMPULSIVE HOARDING 8 0.0249
47 DEVICE COLOUR ISSUE 10 0.0248
48 BRADYKINESIA 146 0.0247
49 PARKINSONIAN GAIT 15 0.0240
50 DELUSIONAL DISORDER, PERSECUTORY TYPE 10 0.0239
51 STEREOTYPY 22 0.0233
52 BASAL GANGLIA INFARCTION 8 0.0233
53 PLEUROTHOTONUS 21 0.0232
54 STOMA SITE PAIN 34 0.0231
55 STOMA SITE INFLAMMATION 17 0.0228
56 SERUM SEROTONIN INCREASED 8 0.0225
57 LIVIDITY 8 0.0218
58 CATHETER SITE IRRITATION 7 0.0210
59 COMPULSIONS 14 0.0210
60 HYPERKINESIA 44 0.0207
61 HALLUCINATION, OLFACTORY 9 0.0207
62 COGWHEEL RIGIDITY 21 0.0200
63 PARKINSON'S DISEASE 50 0.0197
64 DYSKINESIA 784 0.0193
65 YAWNING 51 0.0191
66 STOMA SITE REACTION 13 0.0190
67 EUTHANASIA 6 0.0189
68 DUPLICATE THERAPY ERROR 6 0.0187
69 STOMA SITE HAEMORRHAGE 28 0.0182
70 GAMBLING DISORDER 48 0.0178
71 DROPPED HEAD SYNDROME 7 0.0177
72 LORDOSIS 6 0.0171
73 DEMENTIA WITH LEWY BODIES 19 0.0171
74 MULTIPLE SYSTEM ATROPHY 6 0.0170
75 DRUG EFFECT VARIABLE 18 0.0159
76 OESOPHAGEAL ACHALASIA 10 0.0155
77 ORTHOSTATIC INTOLERANCE 11 0.0153
78 LIBIDO INCREASED 31 0.0153
79 STICKY SKIN 6 0.0150
80 FEAR OF FALLING 12 0.0147
81 SLOW RESPONSE TO STIMULI 19 0.0147
82 HALLUCINATION, VISUAL 299 0.0141
83 CORONARY ARTERY DISSECTION 12 0.0140
84 ENTERAL NUTRITION 8 0.0138
85 ORTHOSTATIC HYPERTENSION 8 0.0137
86 LACK OF SPONTANEOUS SPEECH 6 0.0137
87 THERAPEUTIC PRODUCT EFFECT VARIABLE 53 0.0136
88 SPINAL EPIDURAL HAEMATOMA 8 0.0136
89 HALLUCINATION 986 0.0131
90 AUTONOMIC NEUROPATHY 13 0.0128
91 DELUSION 199 0.0128
92 MUSCLE RIGIDITY 153 0.0128
93 DIET REFUSAL 9 0.0123
94 BINGE EATING 13 0.0120
95 GAMBLING 14 0.0120
96 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 12 0.0119
97 INFUSION SITE ABSCESS 6 0.0119
98 SLEEP TALKING 20 0.0118
99 SINOATRIAL BLOCK 7 0.0117
100 BELLIGERENCE 5 0.0116
101 ORTHOSTATIC HYPOTENSION 197 0.0113
102 AUTONOMIC NERVOUS SYSTEM IMBALANCE 33 0.0113
103 MEDICAL DEVICE CHANGE 6 0.0113
104 MARASMUS 17 0.0112
105 PALLIATIVE CARE 17 0.0111
106 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 5 0.0111
107 DEVICE ALARM ISSUE 20 0.0110
108 DEVICE CONNECTION ISSUE 23 0.0109
109 DELUSIONAL DISORDER, UNSPECIFIED TYPE 8 0.0107
110 WRONG DEVICE USED 7 0.0107
111 INFUSION SITE NODULE 10 0.0104
112 DEVICE LOOSENING 9 0.0104
113 ILLUSION 17 0.0103
114 SEROTONIN SYNDROME 197 0.0102
115 NEUROPSYCHOLOGICAL SYMPTOMS 6 0.0100
116 TRAUMATIC INTRACRANIAL HAEMORRHAGE 9 0.0098
117 HALLUCINATIONS, MIXED 41 0.0097
118 MEDICAL DEVICE SITE INFECTION 6 0.0097
119 PRODUCT RESIDUE PRESENT 52 0.0096
120 CATHETER SITE RELATED REACTION 7 0.0093
121 NONSPECIFIC REACTION 50 0.0091
122 COLITIS MICROSCOPIC 43 0.0091
123 THEFT 6 0.0090
124 SALIVA ALTERED 8 0.0089
125 INFUSION SITE INDURATION 13 0.0088
126 SUSPICIOUSNESS 6 0.0085
127 INFUSION SITE INFLAMMATION 6 0.0085
128 LABILE BLOOD PRESSURE 10 0.0084
129 ACIDOSIS HYPERCHLORAEMIC 5 0.0084
130 DERMATILLOMANIA 5 0.0084
131 REHABILITATION THERAPY 32 0.0083
132 DEVICE KINK 30 0.0082
133 TONGUE MOVEMENT DISTURBANCE 7 0.0082
134 DISINHIBITION 13 0.0081
135 PERSECUTORY DELUSION 20 0.0080
136 OBSESSIVE-COMPULSIVE DISORDER 63 0.0078
137 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 6 0.0078
138 GRIMACING 6 0.0077
139 POSTURE ABNORMAL 25 0.0077
140 INTERMITTENT CLAUDICATION 12 0.0076
141 MEDICAL DEVICE SITE DISCOMFORT 6 0.0075
142 COMPULSIVE SEXUAL BEHAVIOUR 6 0.0074
143 UTERINE PROLAPSE 8 0.0074
144 DRUG EFFECT DELAYED 33 0.0073
145 BLADDER CATHETERISATION 7 0.0072
146 IMPULSIVE BEHAVIOUR 27 0.0072
147 DEVICE OCCLUSION 101 0.0072
148 NOCTURIA 86 0.0071
149 SLOW SPEECH 17 0.0070
150 DYSTONIA 135 0.0070
151 LUMBAR RADICULOPATHY 8 0.0069
152 ANTICHOLINERGIC SYNDROME 11 0.0069
153 STOMA COMPLICATION 7 0.0069
154 MICTURITION URGENCY 78 0.0068
155 PNEUMOPERITONEUM 12 0.0065
156 PARKINSONISM 63 0.0065
157 PROSTATIC OPERATION 7 0.0058
158 INTENTIONAL UNDERDOSE 42 0.0057
159 URETEROLITHIASIS 6 0.0057
160 INHIBITORY DRUG INTERACTION 9 0.0057
161 DROOLING 39 0.0056
162 INFUSION SITE MASS 6 0.0055
163 JUDGEMENT IMPAIRED 8 0.0055
164 DEPRESSIVE SYMPTOM 19 0.0054
165 CATHETER SITE DISCHARGE 6 0.0053
166 FRUSTRATION TOLERANCE DECREASED 43 0.0053
167 HYPOSMIA 8 0.0053
168 MOTOR DYSFUNCTION 53 0.0052
169 MICTURITION DISORDER 18 0.0052
170 GASTROSTOMY 8 0.0052
171 NASAL DISCHARGE DISCOLOURATION 7 0.0051
172 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 10 0.0051
173 HYPERTHERMIA 37 0.0048
174 IMMOBILE 21 0.0048
175 CEREBRAL ATROPHY 19 0.0048
176 HYPERTHERMIA MALIGNANT 7 0.0047
177 PARANOIA 81 0.0047
178 HYPOKINESIA 68 0.0047
179 FEMORAL NECK FRACTURE 24 0.0047
180 DEVICE INEFFECTIVE 5 0.0047
181 DIZZINESS POSTURAL 45 0.0046
182 THERAPEUTIC PRODUCT EFFECT DELAYED 21 0.0046
183 FEELING GUILTY 6 0.0045
184 DEMENTIA 127 0.0045
185 SPEECH DISORDER 232 0.0044
186 SINUS NODE DYSFUNCTION 8 0.0044
187 HEAD TITUBATION 6 0.0044
188 PSYCHOTIC SYMPTOM 9 0.0044
189 DISTRACTIBILITY 5 0.0043
190 LIVING IN RESIDENTIAL INSTITUTION 8 0.0043
191 THERAPEUTIC RESPONSE SHORTENED 141 0.0042
192 BALANCE DISORDER 365 0.0042
193 CATHETER SITE ERYTHEMA 9 0.0042
194 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 11 0.0042
195 CONTRAINDICATED PRODUCT PRESCRIBED 7 0.0042
196 INFUSION SITE BRUISING 9 0.0042
197 FINE MOTOR SKILL DYSFUNCTION 12 0.0041
198 PSYCHOMOTOR HYPERACTIVITY 68 0.0041
199 ABNORMAL DREAMS 112 0.0041
200 WHEELCHAIR USER 18 0.0040
201 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 9 0.0040
202 INFUSION SITE REACTION 12 0.0040
203 TREMOR 663 0.0040
204 MUSCLE CONTRACTURE 8 0.0039
205 BEHAVIOUR DISORDER 21 0.0039
206 INFUSION SITE INFECTION 9 0.0039
207 INCOHERENT 25 0.0039
208 BRADYPHRENIA 25 0.0038
209 SOMNAMBULISM 25 0.0038
210 NEUROLEPTIC MALIGNANT SYNDROME 45 0.0038
211 HYPERPYREXIA 16 0.0038
212 HYPERPHAGIA 15 0.0038
213 DELIRIUM 130 0.0037
214 PNEUMONIA ASPIRATION 93 0.0037
215 ABNORMAL BEHAVIOUR 144 0.0036
216 HYPERVENTILATION 21 0.0036
217 PRESYNCOPE 88 0.0036
218 QUADRIPARESIS 6 0.0036
219 CONFUSIONAL STATE 561 0.0035
220 CATHETER SITE PAIN 9 0.0035
221 GENERAL SYMPTOM 26 0.0035
222 FOOD INTERACTION 6 0.0034
223 GASTROINTESTINAL MOTILITY DISORDER 18 0.0034
224 LIVEDO RETICULARIS 7 0.0033
225 OBSESSIVE THOUGHTS 6 0.0033
226 HIP FRACTURE 107 0.0033
227 STARING 8 0.0033
228 TORTICOLLIS 7 0.0033
229 INGUINAL HERNIA 20 0.0033
230 FALL 1093 0.0033
231 POTENTIATING DRUG INTERACTION 11 0.0033
232 PNEUMONIA KLEBSIELLA 6 0.0033
233 PSYCHOTIC DISORDER 96 0.0032
234 BLOOD PRESSURE FLUCTUATION 78 0.0032
235 DYSARTHRIA 121 0.0032
236 DEVICE DISLOCATION 139 0.0032
237 MOBILITY DECREASED 226 0.0031
238 PHYSICAL DECONDITIONING 8 0.0031
239 SLEEP TERROR 13 0.0031
240 LUMBAR SPINAL STENOSIS 9 0.0031
241 CHOKING 60 0.0031
242 PRODUCT PACKAGING DIFFICULT TO OPEN 8 0.0031
243 COGNITIVE DISORDER 143 0.0031
244 MOVEMENT DISORDER 98 0.0030
245 DIPLEGIA 6 0.0030
246 HYPOMANIA 11 0.0030
247 DEVICE USE ISSUE 52 0.0030
248 SKIN ABRASION 14 0.0030
249 INJECTION SITE NECROSIS 6 0.0029
250 DYSSTASIA 86 0.0029
251 SKIN LACERATION 32 0.0029
252 URINE FLOW DECREASED 7 0.0029
253 FAECALOMA 16 0.0029
254 AGGRESSION 145 0.0029
255 RESTLESSNESS 106 0.0029
256 IMPAIRED SELF-CARE 6 0.0029
257 HALLUCINATION, AUDITORY 46 0.0029
258 URINARY TRACT DISORDER 13 0.0029
259 COMMUNICATION DISORDER 11 0.0029
260 WALKING DISABILITY 6 0.0029
261 FRACTURE 54 0.0028
262 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 25 0.0028
263 SPINAL CORD COMPRESSION 11 0.0028
264 GAIT DISTURBANCE 536 0.0028
265 POOR QUALITY SLEEP 60 0.0028
266 HYPERTENSIVE CRISIS 31 0.0028
267 FEELING COLD 77 0.0028
268 AGITATION 203 0.0028
269 DIPLOPIA 71 0.0027
270 DYSGRAPHIA 18 0.0027
271 BODY TEMPERATURE ABNORMAL 5 0.0027
272 DISORIENTATION 105 0.0026
273 CATHETER SITE INFECTION 10 0.0026
274 MEDICAL DEVICE DISCOMFORT 8 0.0026
275 CLAVICLE FRACTURE 10 0.0026
276 INFUSION SITE ERYTHEMA 22 0.0026
277 NIGHTMARE 89 0.0026
278 THROMBOPHLEBITIS 9 0.0026
279 SOMNOLENCE 515 0.0026
280 UNRESPONSIVE TO STIMULI 66 0.0026
281 INCONTINENCE 27 0.0026
282 MUSCULOSKELETAL STIFFNESS 223 0.0025
283 VOLVULUS 6 0.0025
284 SPUTUM DISCOLOURED 24 0.0025
285 EMBEDDED DEVICE 25 0.0025
286 HYPERSOMNIA 72 0.0025
287 WEIGHT ABNORMAL 6 0.0025
288 SALIVARY HYPERSECRETION 25 0.0025
289 FOOD INTOLERANCE 9 0.0025
290 ALTERED STATE OF CONSCIOUSNESS 53 0.0024
291 INFUSION SITE HAEMORRHAGE 8 0.0024
292 GAIT INABILITY 81 0.0024
293 CHEST INJURY 5 0.0024
294 PRESCRIBED UNDERDOSE 48 0.0024
295 GASTROINTESTINAL TUBE INSERTION 6 0.0024
296 RESTLESS LEGS SYNDROME 43 0.0024
297 CERVICAL VERTEBRAL FRACTURE 8 0.0023
298 DRUG INTERACTION 367 0.0023
299 MIDDLE INSOMNIA 43 0.0023
300 PROSTATOMEGALY 9 0.0023
301 PERONEAL NERVE PALSY 13 0.0023
302 ASPIRATION 25 0.0023
303 PERSONALITY CHANGE 21 0.0023
304 MANIA 37 0.0022
305 EUPHORIC MOOD 23 0.0022
306 TERMINAL STATE 15 0.0022
307 DYSPHAGIA 212 0.0022
308 ANAL INCONTINENCE 20 0.0022
309 HIP SURGERY 12 0.0022
310 DECUBITUS ULCER 18 0.0022
311 BEDRIDDEN 29 0.0022
312 SCREAMING 14 0.0022
313 LUMBAR VERTEBRAL FRACTURE 10 0.0022
314 DYSPHORIA 11 0.0022
315 HEAD INJURY 68 0.0021
316 INITIAL INSOMNIA 22 0.0021
317 TENSION 13 0.0021
318 APPLICATION SITE REACTION 15 0.0021
319 TRISMUS 11 0.0021
320 MUSCLE FATIGUE 9 0.0021
321 LISTLESS 7 0.0021
322 DEVICE PHYSICAL PROPERTY ISSUE 16 0.0021
323 SHOCK HAEMORRHAGIC 17 0.0021
324 SLEEP DISORDER 147 0.0021
325 HYPERTONIC BLADDER 6 0.0021
326 DEVICE ISSUE 186 0.0021
327 BLOOD PRESSURE DECREASED 137 0.0021
328 DEVICE POWER SOURCE ISSUE 6 0.0021
329 DYSPHEMIA 9 0.0021
330 RESPIRATORY ACIDOSIS 8 0.0020
331 ENERGY INCREASED 12 0.0020
332 HOSPICE CARE 20 0.0020
333 HYPOPNOEA 7 0.0020
334 INJECTION SITE NODULE 22 0.0020
335 FLUID INTAKE REDUCED 10 0.0020
336 CATHETER SITE HAEMORRHAGE 5 0.0020
337 HYPOPHAGIA 51 0.0020
338 CONSTIPATION 433 0.0020
339 HEAD DISCOMFORT 35 0.0020
340 NEURALGIA 48 0.0020
341 MASTICATION DISORDER 6 0.0020
342 SPINAL OPERATION 24 0.0019
343 WRIST FRACTURE 23 0.0019
344 RESPIRATORY RATE DECREASED 6 0.0019
345 JOINT DISLOCATION 20 0.0019
346 THINKING ABNORMAL 35 0.0019
347 DECREASED INTEREST 11 0.0019
348 BRUXISM 10 0.0019
349 DISTURBANCE IN ATTENTION 99 0.0018
350 JAW DISORDER 10 0.0018
351 GASTROINTESTINAL SOUNDS ABNORMAL 9 0.0018
352 SPINAL COMPRESSION FRACTURE 15 0.0018
353 PANIC DISORDER 7 0.0018
354 PELVIC FRACTURE 14 0.0018
355 MALIGNANT MELANOMA 24 0.0018
356 SYNCOPE 179 0.0018
357 PSYCHIATRIC SYMPTOM 13 0.0018
358 ABNORMAL LOSS OF WEIGHT 12 0.0018
359 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 18 0.0018
360 SOCIAL AVOIDANT BEHAVIOUR 10 0.0017
361 HYPERREFLEXIA 6 0.0017
362 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 122 0.0017
363 LOGORRHOEA 6 0.0017
364 RIB FRACTURE 35 0.0017
365 MUSCULOSKELETAL DISORDER 32 0.0017
366 DRY MOUTH 135 0.0017
367 PANIC REACTION 12 0.0017
368 RHABDOMYOLYSIS 69 0.0017
369 CRANIOCEREBRAL INJURY 5 0.0017
370 PULMONARY THROMBOSIS 18 0.0016
371 DEPRESSED MOOD 86 0.0016
372 UROSEPSIS 15 0.0016
373 HYPOTONIA 16 0.0016
374 HYPOTENSION 321 0.0016
375 DRUG TOLERANCE 8 0.0016
376 TROPONIN INCREASED 12 0.0016
377 FEELING JITTERY 30 0.0016
378 HYPERTONIA 9 0.0016
379 BOWEL MOVEMENT IRREGULARITY 12 0.0016
380 PETIT MAL EPILEPSY 8 0.0016
381 CACHEXIA 8 0.0016
382 URINARY TRACT INFECTION 265 0.0016
383 DYSPHONIA 90 0.0015
384 CATATONIA 8 0.0015
385 MAJOR DEPRESSION 11 0.0015
386 PERFORMANCE STATUS DECREASED 7 0.0015
387 PRESCRIBED OVERDOSE 29 0.0015
388 VITAMIN B12 DEFICIENCY 6 0.0015
389 MUSCLE TIGHTNESS 24 0.0015
390 FEEDING DISORDER 30 0.0015
391 AFFECT LABILITY 14 0.0015
392 SPINAL STENOSIS 6 0.0015
393 URINARY INCONTINENCE 43 0.0014
394 ANOSMIA 21 0.0014
395 GENERALISED TONIC-CLONIC SEIZURE 24 0.0014
396 GENERAL PHYSICAL HEALTH DETERIORATION 166 0.0014
397 HYPERHIDROSIS 184 0.0014
398 PRODUCT PRESCRIBING ERROR 34 0.0014
399 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
400 ERYTHEMA NODOSUM 5 0.0014
401 LIMB DISCOMFORT 44 0.0014
402 INSOMNIA 378 0.0014
403 APHTHOUS ULCER 11 0.0014
404 BODY HEIGHT DECREASED 15 0.0014
405 PRODUCT DISPENSING ISSUE 6 0.0014
406 DEVICE PLACEMENT ISSUE 5 0.0014
407 TEARFULNESS 6 0.0014
408 APHASIA 42 0.0014
409 MENTAL DISORDER 60 0.0014
410 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
411 SUBARACHNOID HAEMORRHAGE 14 0.0014
412 APATHY 20 0.0014
413 COORDINATION ABNORMAL 19 0.0014
414 DIZZINESS 675 0.0014
415 CATHETERISATION CARDIAC 6 0.0014
416 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 65 0.0014
417 CATARACT OPERATION 8 0.0013
418 POLYURIA 11 0.0013
419 DEPRESSED LEVEL OF CONSCIOUSNESS 53 0.0013
420 PARTIAL SEIZURES 7 0.0013
421 ACUTE CORONARY SYNDROME 11 0.0013
422 PEMPHIGOID 10 0.0013
423 DRUG EFFECT INCOMPLETE 48 0.0013
424 MYOCARDIAL ISCHAEMIA 15 0.0013
425 LOSS OF CONSCIOUSNESS 168 0.0013
426 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
427 COMPRESSION FRACTURE 7 0.0013
428 COLD SWEAT 23 0.0013
429 ANXIETY 371 0.0013
430 EYE OPERATION 6 0.0013
431 UNINTENTIONAL MEDICAL DEVICE REMOVAL 15 0.0013
432 ABASIA 32 0.0013
433 FORMICATION 9 0.0013
434 SCOLIOSIS 8 0.0013
435 FEELING OF DESPAIR 6 0.0013
436 ERECTILE DYSFUNCTION 33 0.0013
437 DUODENAL ULCER 9 0.0013
438 INFUSION SITE SWELLING 8 0.0013
439 BLEPHAROSPASM 8 0.0013
440 NEUTROPHIL COUNT INCREASED 13 0.0013
441 CHOKING SENSATION 7 0.0013
442 EATING DISORDER 27 0.0013
443 PHOTOPSIA 8 0.0013
444 CHRONIC LYMPHOCYTIC LEUKAEMIA 6 0.0013
445 SEDATION 33 0.0013
446 SUBDURAL HAEMATOMA 18 0.0013
447 THERAPEUTIC RESPONSE UNEXPECTED 56 0.0012
448 INFUSION SITE PAIN 16 0.0012
449 HIP ARTHROPLASTY 19 0.0012
450 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21 0.0012
451 FEELING ABNORMAL 293 0.0012
452 CONDITION AGGRAVATED 370 0.0012
453 MUSCLE TWITCHING 28 0.0012
454 DRUG LEVEL INCREASED 20 0.0012
455 AORTIC DISSECTION 5 0.0012
456 BLOOD PRESSURE ABNORMAL 24 0.0012
457 PULMONARY HYPERTENSION 25 0.0012
458 URINARY RETENTION 40 0.0012
459 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
460 MENTAL IMPAIRMENT 29 0.0012
461 ERYSIPELAS 6 0.0012
462 PRODUCT DISPENSING ERROR 26 0.0012
463 NERVOUSNESS 62 0.0012
464 SENSORY DISTURBANCE 19 0.0012
465 TOOTH FRACTURE 13 0.0012
466 SLUGGISHNESS 12 0.0012
467 CARDIAC PACEMAKER INSERTION 7 0.0012
468 FOOT DEFORMITY 13 0.0012
469 RETCHING 25 0.0012
470 LACERATION 11 0.0012
471 PRODUCT COLOUR ISSUE 6 0.0012
472 VERTIGO 71 0.0012
473 UNEVALUABLE EVENT 88 0.0012
474 MUSCULAR WEAKNESS 132 0.0012
475 ANGER 39 0.0012
476 FEAR 31 0.0012
477 MEMORY IMPAIRMENT 158 0.0011
478 CEREBRAL HAEMORRHAGE 41 0.0011
479 DEFAECATION URGENCY 8 0.0011
480 GROIN PAIN 10 0.0011
481 SMALL INTESTINAL OBSTRUCTION 14 0.0011
482 WEIGHT DECREASED 316 0.0011
483 FEMUR FRACTURE 35 0.0011
484 SENSORY LOSS 9 0.0011
485 PARALYSIS 16 0.0011
486 ADVERSE DRUG REACTION 100 0.0011
487 DECREASED ACTIVITY 12 0.0011
488 PERIPHERAL SWELLING 170 0.0011
489 PANIC ATTACK 40 0.0011
490 MYDRIASIS 14 0.0011
491 PRODUCT PHYSICAL ISSUE 22 0.0011
492 NERVE COMPRESSION 10 0.0011
493 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
494 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
495 FEELING DRUNK 8 0.0011
496 TENDON DISORDER 7 0.0011
497 DEPRESSION 243 0.0011
498 WALKING AID USER 7 0.0011
499 TENDON RUPTURE 13 0.0011
500 SKIN MASS 7 0.0010
501 MYOCARDITIS 12 0.0010
502 MYOPATHY 9 0.0010
503 TACHYPNOEA 14 0.0010
504 PRODUCT COMMUNICATION ISSUE 9 0.0010
505 DEHYDRATION 136 0.0010
506 CHROMATURIA 23 0.0010
507 AFFECTIVE DISORDER 8 0.0010
508 EPILEPSY 31 0.0010
509 BLOOD PRESSURE INCREASED 155 0.0010
510 MYOCLONUS 12 0.0010
511 HAEMATOMA 26 0.0010
512 HEPATITIS CHOLESTATIC 6 0.0010
513 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
514 OEDEMA PERIPHERAL 121 0.0010
515 ECONOMIC PROBLEM 15 0.0010
516 BURSITIS 12 0.0010
517 CORONARY ARTERIAL STENT INSERTION 5 0.0010
518 DRUG EFFECT DECREASED 53 0.0010
519 MALNUTRITION 11 0.0010
520 THERAPEUTIC PRODUCT EFFECT DECREASED 44 0.0010
521 TREATMENT NONCOMPLIANCE 53 0.0010
522 IMPAIRED DRIVING ABILITY 11 0.0010
523 TONGUE DISORDER 7 0.0010
524 DERMATITIS BULLOUS 7 0.0010
525 INTERNAL HAEMORRHAGE 11 0.0010
526 LIMB INJURY 26 0.0010
527 INTESTINAL OBSTRUCTION 36 0.0010
528 DERMATITIS ALLERGIC 12 0.0010
529 KNEE ARTHROPLASTY 20 0.0009
530 PERIPHERAL COLDNESS 13 0.0009
531 SUDDEN DEATH 10 0.0009
532 SUICIDE ATTEMPT 57 0.0009
533 SUICIDAL IDEATION 86 0.0009
534 DEVICE DIFFICULT TO USE 62 0.0009
535 ENCEPHALOPATHY 23 0.0009
536 C-REACTIVE PROTEIN INCREASED 34 0.0009
537 PRODUCT DOSE OMISSION 61 0.0009
538 HIATUS HERNIA 12 0.0009
539 MUSCLE STRAIN 8 0.0009
540 ASTHENIA 347 0.0009
541 LETHARGY 53 0.0009
542 INCORRECT DOSE ADMINISTERED BY DEVICE 24 0.0009
543 SPINAL OSTEOARTHRITIS 8 0.0009
544 CORONAVIRUS INFECTION 6 0.0009
545 BLADDER DISORDER 9 0.0009
546 COUGH 254 0.0009
547 DENTAL CARIES 10 0.0009
548 BRAIN INJURY 9 0.0009
549 HYPERTENSION 190 0.0009
550 UNDERDOSE 65 0.0009
551 THERAPY NON-RESPONDER 40 0.0009
552 COLITIS ISCHAEMIC 6 0.0009
553 HYPOTHERMIA 9 0.0009
554 DECREASED APPETITE 206 0.0009
555 EYELID PTOSIS 9 0.0009
556 LEUKOCYTOSIS 16 0.0009
557 MUSCLE SPASMS 162 0.0009
558 CHOLECYSTITIS ACUTE 5 0.0009
559 MOOD ALTERED 24 0.0009
560 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 41 0.0009
561 NECK PAIN 49 0.0009
562 EXERCISE TOLERANCE DECREASED 5 0.0009
563 POLLAKIURIA 36 0.0009
564 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
565 EXTRASYSTOLES 6 0.0009
566 CEREBRAL INFARCTION 21 0.0009
567 ASPHYXIA 7 0.0009
568 HYPONATRAEMIA 48 0.0009
569 CONTUSION 82 0.0009
570 HAND FRACTURE 6 0.0008
571 DYSURIA 31 0.0008
572 ABDOMINAL DISTENSION 87 0.0008
573 BASAL CELL CARCINOMA 13 0.0008
574 SARS-COV-2 TEST POSITIVE 11 0.0008
575 DRUG PRESCRIBING ERROR 16 0.0008
576 SENSATION OF FOREIGN BODY 7 0.0008
577 COMPLICATION ASSOCIATED WITH DEVICE 12 0.0008
578 LIGAMENT SPRAIN 8 0.0008
579 DEVICE LEAKAGE 35 0.0008
580 UPPER LIMB FRACTURE 16 0.0008
581 SPINAL FRACTURE 16 0.0008
582 RESPIRATORY DISTRESS 22 0.0008
583 TOXIC SKIN ERUPTION 8 0.0008
584 APHONIA 11 0.0008
585 DRY THROAT 8 0.0008
586 ISCHAEMIC STROKE 14 0.0008
587 THIRST 14 0.0008
588 FEELING HOT 48 0.0008
589 MYOSITIS 7 0.0008
590 CRYING 28 0.0008
591 MALAISE 337 0.0008
592 ANGINA PECTORIS 22 0.0008
593 SEXUAL DYSFUNCTION 9 0.0008
594 ROAD TRAFFIC ACCIDENT 32 0.0008
595 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
596 DEVICE BREAKAGE 31 0.0008
597 PRODUCT DOSE OMISSION ISSUE 224 0.0008
598 AGEUSIA 19 0.0008
599 IRON DEFICIENCY ANAEMIA 7 0.0008
600 ACTIVITIES OF DAILY LIVING IMPAIRED 15 0.0008
601 ATRIAL FIBRILLATION 73 0.0007
602 APPENDICITIS 7 0.0007
603 STENT PLACEMENT 6 0.0007
604 SKIN CANCER 16 0.0007
605 TACHYCARDIA 66 0.0007
606 PRODUCT DOSE OMISSION IN ERROR 21 0.0007
607 DEATH 638 0.0007
608 ADVERSE EVENT 68 0.0007
609 BRADYCARDIA 39 0.0007
610 COMA 35 0.0007
611 RESPIRATORY DEPRESSION 9 0.0007
612 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
613 LOWER LIMB FRACTURE 14 0.0007
614 CYSTITIS 23 0.0007
615 VITREOUS FLOATERS 7 0.0007
616 MITRAL VALVE INCOMPETENCE 8 0.0007
617 ROTATOR CUFF SYNDROME 9 0.0007
618 PRODUCT USE COMPLAINT 11 0.0007
619 PALLOR 19 0.0007
620 SKIN ULCER 18 0.0007
621 BODY TEMPERATURE INCREASED 14 0.0007
622 HEART RATE DECREASED 24 0.0007
623 NEUROPATHY PERIPHERAL 65 0.0007
624 SPINAL PAIN 8 0.0007
625 ACUTE MYOCARDIAL INFARCTION 20 0.0007
626 ACUTE RESPIRATORY FAILURE 13 0.0007
627 HERNIA 13 0.0007
628 JOINT RANGE OF MOTION DECREASED 9 0.0007
629 BACK PAIN 154 0.0007
630 KIDNEY INFECTION 13 0.0007
631 EXPIRED PRODUCT ADMINISTERED 22 0.0007
632 CONTRAINDICATED PRODUCT ADMINISTERED 20 0.0007
633 CARDIAC FAILURE 53 0.0007
634 RESPIRATORY TRACT INFECTION 17 0.0007
635 THYROID DISORDER 10 0.0006
636 THROAT IRRITATION 29 0.0006
637 CONCUSSION 5 0.0006
638 AGRANULOCYTOSIS 12 0.0006
639 WITHDRAWAL SYNDROME 27 0.0006
640 APPLICATION SITE IRRITATION 8 0.0006
641 PNEUMONIA 208 0.0006
642 OESOPHAGITIS 7 0.0006
643 BLINDNESS UNILATERAL 9 0.0006
644 SPINAL DISORDER 6 0.0006
645 NAUSEA 501 0.0006
646 BLOOD URINE PRESENT 12 0.0006
647 INTENTIONAL DOSE OMISSION 18 0.0006
648 SLEEP APNOEA SYNDROME 12 0.0006
649 INCREASED APPETITE 12 0.0006
650 SCIATICA 10 0.0006
651 ATRIAL FLUTTER 5 0.0006
652 METABOLIC ACIDOSIS 20 0.0006
653 SKIN INFECTION 7 0.0006
654 FATIGUE 482 0.0006
655 RESPIRATORY FAILURE 45 0.0006
656 APPLICATION SITE PRURITUS 14 0.0006
657 PRODUCT AVAILABILITY ISSUE 14 0.0006
658 AMNESIA 40 0.0006
659 SURGERY 36 0.0006
660 VISUAL IMPAIRMENT 76 0.0006
661 JOINT INJURY 13 0.0006
662 INABILITY TO AFFORD MEDICATION 6 0.0006
663 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
664 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
665 LOWER RESPIRATORY TRACT INFECTION 27 0.0006
666 PRODUCT TASTE ABNORMAL 8 0.0006
667 BLOOD IRON DECREASED 7 0.0006
668 ATAXIA 7 0.0006
669 DRUG DISPENSING ERROR 9 0.0006
670 CHOLECYSTITIS 7 0.0006
671 DRUG INEFFECTIVE 772 0.0006
672 THERAPY CESSATION 30 0.0006
673 BLOOD SODIUM DECREASED 11 0.0006
674 DISEASE PROGRESSION 69 0.0006
675 ILL-DEFINED DISORDER 35 0.0006
676 HYPOAESTHESIA 86 0.0006
677 LOCAL SWELLING 10 0.0006
678 POST PROCEDURAL COMPLICATION 11 0.0006
679 HOSPITALISATION 87 0.0006
680 RENAL PAIN 6 0.0006
681 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
682 EXTRAPYRAMIDAL DISORDER 14 0.0006
683 SECRETION DISCHARGE 7 0.0006
684 RHINORRHOEA 36 0.0006
685 CELLULITIS 28 0.0006
686 CEREBROVASCULAR ACCIDENT 94 0.0006
687 BACK DISORDER 9 0.0006
688 OSTEOMYELITIS 10 0.0006
689 BIPOLAR DISORDER 6 0.0006
690 BACK INJURY 6 0.0006
691 OXYGEN SATURATION DECREASED 31 0.0006
692 DEVICE DELIVERY SYSTEM ISSUE 15 0.0005
693 PULMONARY EMBOLISM 52 0.0005
694 PALPITATIONS 64 0.0005
695 STAPHYLOCOCCAL INFECTION 18 0.0005
696 MENTAL STATUS CHANGES 15 0.0005
697 NODULE 7 0.0005
698 BACTERIAL INFECTION 10 0.0005
699 DEFORMITY 5 0.0005
700 MUSCULOSKELETAL PAIN 28 0.0005
701 APPLICATION SITE ERYTHEMA 14 0.0005
702 JOINT STIFFNESS 14 0.0005
703 DYSPNOEA EXERTIONAL 20 0.0005
704 CIRCULATORY COLLAPSE 9 0.0005
705 SEIZURE 61 0.0005
706 COMPLETED SUICIDE 44 0.0005
707 ADVERSE REACTION 7 0.0005
708 DEVICE DEFECTIVE 9 0.0005
709 EMOTIONAL DISORDER 16 0.0005
710 DRUG INTOLERANCE 50 0.0005
711 TENDONITIS 8 0.0005
712 NEUROTOXICITY 9 0.0005
713 VISION BLURRED 70 0.0005
714 PROSTATIC SPECIFIC ANTIGEN INCREASED 7 0.0005
715 CHEST DISCOMFORT 52 0.0005
716 DRUG WITHDRAWAL SYNDROME 44 0.0005
717 POLYNEUROPATHY 6 0.0005
718 ABDOMINAL PAIN 116 0.0005
719 GASTROENTERITIS VIRAL 9 0.0005
720 DYSPEPSIA 49 0.0005
721 ACUTE KIDNEY INJURY 76 0.0005
722 PARAESTHESIA 78 0.0005
723 OSTEOARTHRITIS 21 0.0005
724 SEASONAL ALLERGY 7 0.0005
725 HEPATOCELLULAR INJURY 7 0.0005
726 SEPSIS 55 0.0005
727 TASTE DISORDER 10 0.0005
728 DYSPNOEA 279 0.0005
729 HOT FLUSH 37 0.0005
730 JOINT SWELLING 59 0.0005
731 CHOLELITHIASIS 16 0.0005
732 HYPOACUSIS 21 0.0005
733 CATARACT 29 0.0005
734 ARRHYTHMIA 23 0.0005
735 PHARYNGITIS 6 0.0005
736 INTENTIONAL OVERDOSE 31 0.0005
737 ILEUS 6 0.0005
738 MYALGIA 82 0.0005
739 IRRITABILITY 29 0.0005
740 CARDIAC DISORDER 45 0.0005
741 PAIN IN EXTREMITY 141 0.0005
742 DERMATITIS 10 0.0005
743 FACE OEDEMA 8 0.0005
744 MUSCLE ATROPHY 6 0.0005
745 GASTRIC ULCER 9 0.0005
746 CARDIOVASCULAR DISORDER 12 0.0005
747 PRODUCT SUBSTITUTION ISSUE 27 0.0005
748 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 95 0.0005
749 ERUCTATION 9 0.0005
750 ABDOMINAL DISCOMFORT 78 0.0005
751 MUSCULOSKELETAL DISCOMFORT 8 0.0005
752 ACCIDENTAL OVERDOSE 17 0.0005
753 PHARMACEUTICAL PRODUCT COMPLAINT 12 0.0005
754 VOMITING 215 0.0005
755 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 25 0.0005
756 TOOTH INFECTION 6 0.0005
757 DEVICE RELATED INFECTION 7 0.0005
758 SOPOR 6 0.0005
759 MUSCULOSKELETAL CHEST PAIN 7 0.0005
760 LIP SWELLING 15 0.0004
761 TOOTH DISORDER 10 0.0004
762 THERAPY INTERRUPTED 32 0.0004
763 QUALITY OF LIFE DECREASED 6 0.0004
764 BRAIN FOG 7 0.0004
765 ORAL PAIN 10 0.0004
766 INTENTIONAL SELF-INJURY 9 0.0004
767 CYANOSIS 7 0.0004
768 HEART RATE IRREGULAR 10 0.0004
769 RENAL IMPAIRMENT 37 0.0004
770 DERMATITIS CONTACT 5 0.0004
771 THROMBOCYTOPENIA 49 0.0004
772 CORONARY ARTERY OCCLUSION 6 0.0004
773 NEPHROLITHIASIS 20 0.0004
774 INFECTION 63 0.0004
775 SHOCK 10 0.0004
776 PERITONITIS 9 0.0004
777 ORAL DISCOMFORT 6 0.0004
778 CONJUNCTIVITIS 8 0.0004
779 PYREXIA 148 0.0004
780 DISCOMFORT 26 0.0004
781 DRUG ADMINISTRATION ERROR 13 0.0004
782 COVID-19 PNEUMONIA 5 0.0004
783 INTENTIONAL PRODUCT MISUSE 37 0.0004
784 EXTRA DOSE ADMINISTERED 17 0.0004
785 ACCIDENT 5 0.0004
786 NERVOUS SYSTEM DISORDER 13 0.0004
787 RENAL FAILURE 55 0.0004
788 MEDICATION ERROR 23 0.0004
789 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
790 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 74 0.0004
791 CHEST PAIN 76 0.0004
792 CARDIO-RESPIRATORY ARREST 17 0.0004
793 DYSGEUSIA 30 0.0004
794 DEVICE USE ERROR 14 0.0004
795 CYST 5 0.0004
796 COLON CANCER 6 0.0004
797 BLOOD CREATININE INCREASED 26 0.0004
798 PRODUCTIVE COUGH 19 0.0004
799 HAEMATEMESIS 10 0.0004
800 FLUSHING 40 0.0004
801 INTERSTITIAL LUNG DISEASE 19 0.0004
802 DEVICE DEPLOYMENT ISSUE 5 0.0004
803 GOUT 7 0.0004
804 MYOCARDIAL INFARCTION 68 0.0004
805 FLATULENCE 22 0.0004
806 CARDIAC ARREST 32 0.0004
807 RASH PRURITIC 21 0.0004
808 TOOTH LOSS 8 0.0004
809 DRY EYE 19 0.0004
810 MOUTH ULCERATION 8 0.0004
811 PNEUMOTHORAX 6 0.0004
812 PAIN 232 0.0004
813 HEADACHE 236 0.0004
814 HEART RATE INCREASED 37 0.0004
815 RASH MACULAR 13 0.0004
816 FOOT FRACTURE 7 0.0004
817 FAECES DISCOLOURED 8 0.0004
818 LUNG DISORDER 18 0.0004
819 EYE DISORDER 12 0.0004
820 DEPENDENCE 20 0.0004
821 SKIN LESION 10 0.0004
822 GLAUCOMA 7 0.0004
823 ANAEMIA 69 0.0004
824 ARTHRALGIA 150 0.0004
825 FUNGAL INFECTION 12 0.0004
826 LEUKOPENIA 18 0.0004
827 BLOOD UREA INCREASED 6 0.0004
828 WOUND 10 0.0004
829 ARTHRITIS 28 0.0004
830 HEMIPARESIS 6 0.0004
831 FLUID RETENTION 18 0.0004
832 SWOLLEN TONGUE 11 0.0004
833 OEDEMA 19 0.0003
834 RECTAL HAEMORRHAGE 15 0.0003
835 TINNITUS 16 0.0003
836 OVERDOSE 75 0.0003
837 PRODUCT ADMINISTRATION ERROR 7 0.0003
838 GASTROINTESTINAL DISORDER 31 0.0003
839 MOOD SWINGS 11 0.0003
840 DRUG DOSE OMISSION 57 0.0003
841 GASTRITIS 9 0.0003
842 INFLUENZA 38 0.0003
843 NASAL CONGESTION 20 0.0003
844 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 24 0.0003
845 LOCALISED INFECTION 8 0.0003
846 SKIN DISORDER 11 0.0003
847 PLEURAL EFFUSION 20 0.0003
848 LIVER INJURY 8 0.0003
849 PRURITUS GENERALISED 7 0.0003
850 ANKLE FRACTURE 5 0.0003
851 EPISTAXIS 24 0.0003
852 SWELLING 30 0.0003
853 BLISTER 18 0.0003
854 INCORRECT DOSE ADMINISTERED 73 0.0003
855 PHOTOPHOBIA 6 0.0003
856 ABDOMINAL PAIN LOWER 8 0.0003
857 CHILLS 37 0.0003
858 EMOTIONAL DISTRESS 38 0.0003
859 OROPHARYNGEAL PAIN 29 0.0003
860 PULMONARY OEDEMA 14 0.0003
861 HYPOXIA 11 0.0003
862 CARDIAC FAILURE CONGESTIVE 25 0.0003
863 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
864 PRODUCT USE ISSUE 58 0.0003
865 INCORRECT ROUTE OF DRUG ADMINISTRATION 11 0.0003
866 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
867 ARTHROPATHY 17 0.0003
868 DIARRHOEA 196 0.0003
869 PERICARDIAL EFFUSION 7 0.0003
870 COVID-19 53 0.0003
871 ERYTHEMA 62 0.0003
872 GASTROINTESTINAL HAEMORRHAGE 25 0.0003
873 THROMBOSIS 24 0.0003
874 THERAPEUTIC RESPONSE DECREASED 18 0.0003
875 THROAT TIGHTNESS 8 0.0003
876 WEIGHT INCREASED 66 0.0003
877 BLINDNESS 12 0.0003
878 HAEMATURIA 10 0.0003
879 INFLUENZA LIKE ILLNESS 24 0.0003
880 INFLAMMATION 15 0.0003
881 RESPIRATORY ARREST 8 0.0003
882 HYPOGLYCAEMIA 14 0.0003
883 DRUG ABUSE 24 0.0003
884 GASTROOESOPHAGEAL REFLUX DISEASE 23 0.0003
885 BURNING SENSATION 20 0.0003
886 HYPERKALAEMIA 10 0.0003
887 INJURY 20 0.0003
888 EYE PAIN 16 0.0003
889 SKIN DISCOLOURATION 13 0.0003
890 DRUG ERUPTION 5 0.0003
891 ALOPECIA 55 0.0003
892 PRODUCT ADHESION ISSUE 10 0.0003
893 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
894 LACTIC ACIDOSIS 9 0.0003
895 SWELLING FACE 18 0.0003
896 HYPERGLYCAEMIA 10 0.0003
897 OFF LABEL USE 240 0.0003
898 MELAENA 6 0.0003
899 BLOOD GLUCOSE ABNORMAL 5 0.0003
900 BRONCHITIS 20 0.0003
901 WHEEZING 16 0.0003
902 RASH MACULO-PAPULAR 6 0.0003
903 RESPIRATORY DISORDER 8 0.0003
904 ABDOMINAL PAIN UPPER 55 0.0003
905 RASH 116 0.0003
906 CORONARY ARTERY DISEASE 8 0.0003
907 COLITIS 10 0.0003
908 GASTRIC DISORDER 9 0.0003
909 HYPOKALAEMIA 12 0.0003
910 RENAL FAILURE ACUTE 11 0.0003
911 NEOPLASM MALIGNANT 17 0.0003
912 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
913 PROSTATE CANCER 20 0.0002
914 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
915 RED BLOOD CELL COUNT DECREASED 7 0.0002
916 CONVULSION 14 0.0002
917 NASOPHARYNGITIS 45 0.0002
918 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
919 INJECTION SITE BRUISING 19 0.0002
920 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
921 HAEMATOCHEZIA 13 0.0002
922 BLOOD POTASSIUM DECREASED 7 0.0002
923 LACRIMATION INCREASED 7 0.0002
924 PRURITUS 88 0.0002
925 APPLICATION SITE PAIN 5 0.0002
926 PRODUCT USE IN UNAPPROVED INDICATION 56 0.0002
927 ILLNESS 23 0.0002
928 FREQUENT BOWEL MOVEMENTS 6 0.0002
929 TOXICITY TO VARIOUS AGENTS 37 0.0002
930 INJECTION SITE ERYTHEMA 27 0.0002
931 NIGHT SWEATS 7 0.0002
932 DEEP VEIN THROMBOSIS 14 0.0002
933 RENAL DISORDER 10 0.0002
934 HEPATIC FUNCTION ABNORMAL 8 0.0002
935 INCORRECT DRUG ADMINISTRATION DURATION 6 0.0002
936 PAIN IN JAW 6 0.0002
937 OCULAR HYPERAEMIA 10 0.0002
938 DIABETES MELLITUS 16 0.0002
939 RASH ERYTHEMATOUS 10 0.0002
940 HERPES ZOSTER 12 0.0002
941 BLOOD GLUCOSE DECREASED 10 0.0002
942 PANCREATIC CARCINOMA 6 0.0002
943 HAEMOGLOBIN DECREASED 21 0.0002
944 LABORATORY TEST ABNORMAL 6 0.0002
945 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
946 OSTEOPOROSIS 8 0.0002
947 EXPOSURE DURING PREGNANCY 12 0.0002
948 DRUG-INDUCED LIVER INJURY 6 0.0002
949 DEAFNESS 5 0.0002
950 EAR INFECTION 5 0.0002
951 SINUSITIS 19 0.0002
952 CHRONIC KIDNEY DISEASE 13 0.0002
953 LYMPHADENOPATHY 6 0.0002
954 INJECTION SITE PRURITUS 11 0.0002
955 MIGRAINE 15 0.0002
956 DEVICE EXPULSION 10 0.0002
957 HAEMORRHAGE 16 0.0002
958 SKIN IRRITATION 7 0.0002
959 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
960 PRODUCT QUALITY ISSUE 20 0.0001
961 HYPERSENSITIVITY 27 0.0001
962 SEPTIC SHOCK 6 0.0001
963 ANGIOEDEMA 6 0.0001
964 DRY SKIN 18 0.0001
965 BLOOD GLUCOSE INCREASED 25 0.0001
966 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
967 INJECTION SITE REACTION 9 0.0001
968 INJECTION SITE SWELLING 10 0.0001
969 DISEASE RECURRENCE 6 0.0001
970 INJECTION SITE HAEMORRHAGE 10 0.0001
971 ABORTION SPONTANEOUS 5 0.0001
972 BONE PAIN 7 0.0001
973 DEVICE MALFUNCTION 8 0.0001
974 URTICARIA 19 0.0001
975 NEUTROPENIA 15 0.0001
976 BREAST CANCER 10 0.0001
977 INFUSION RELATED REACTION 7 0.0001
978 EYE IRRITATION 6 0.0001
979 PSORIASIS 13 0.0001
980 ASTHMA 11 0.0001
981 ECZEMA 5 0.0001
982 PLATELET COUNT DECREASED 10 0.0001
983 DRUG DEPENDENCE 15 0.0001
984 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
985 HEPATIC ENZYME INCREASED 6 0.0001
986 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
987 NO ADVERSE EVENT 15 0.0001
988 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
989 TREATMENT FAILURE 6 0.0001
990 INJECTION SITE PAIN 22 0.0001
991 RHEUMATOID ARTHRITIS 8 0.0001